phloroglucinol has been researched along with Leishmaniasis, Visceral in 1 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rachidi, N | 1 |
Taly, JF | 1 |
Durieu, E | 1 |
Leclercq, O | 1 |
Aulner, N | 1 |
Prina, E | 1 |
Pescher, P | 1 |
Notredame, C | 1 |
Meijer, L | 1 |
Späth, GF | 1 |
1 other study available for phloroglucinol and Leishmaniasis, Visceral
Article | Year |
---|---|
Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection.
Topics: Animals; Benzamides; Casein Kinase I; Conserved Sequence; Cricetinae; Female; Imidazoles; Indoles; I | 2014 |